Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Fibrosis (IF)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Temporarily pausedNCT01021943
What this trial is testing

Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Instituto Nacional de Cardiologia Ignacio Chavez 40
Testing effectiveness (Phase 2)WithdrawnNCT00878761
What this trial is testing

Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)

Who this might be right for
Chronic Allograft Dysfunction
Stromedix, Inc. 48
Not applicableLooking for participantsNCT01531257
What this trial is testing

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Who this might be right for
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University 1,000
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194